Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT02383927What this trial is testingPhase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsWho this might be right forThyroid CancerSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)HRAS Mutant Tumor+1 more Kura Oncology, Inc. 63
Early research (Phase 1)Study completedNCT00948467What this trial is testingStudy of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesWho this might be right forAdvanced Non-hematologic MalignanciesAdvanced Metastatic Melanoma Millennium Pharmaceuticals, Inc. 51
Testing effectiveness (Phase 2)Ended earlyNCT00861965What this trial is testingBioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood CancersWho this might be right forAdvanced or Refractory Leukemia, Lymphoma, Multiple Myeloma Mirror Biologics, Inc. 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00867230What this trial is testingFTS Study in Patients With Advanced Hematologic MalignanciesWho this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT02992171What this trial is testingPrimary Palliative Care for Patients With Advanced Hematologic MalignanciesWho this might be right forAdvanced Cancer University of Pittsburgh 60
Testing effectiveness (Phase 2)Looking for participantsNCT04068597What this trial is testingStudy to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesWho this might be right forHaematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more CellCentric Ltd. 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT07195916What this trial is testingEvaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesWho this might be right forSolid TumorsHematologic Malignancies Incyte Corporation 280
Early research (Phase 1)Active Not RecruitingNCT06645886What this trial is testingInvestigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic MalignanciesWho this might be right forHematologic MalignanciesAdult Kumquat Biosciences Inc. 13
Not applicableNot Yet RecruitingNCT07234630What this trial is testingRole of Fibrinolytic Activity in Neoplastic Pathologies Complicated by CoagulopathyWho this might be right forHematologic NeoplasmsSolid Tumor Metastatic Cancer Advanced CancerDisseminated Intravascular Coagulation University Hospital, Strasbourg, France 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136What this trial is testingTesting Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167What this trial is testingTesting AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 19
Very early researchUnknownNCT04700319What this trial is testingCAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological MalignanciesWho this might be right forCAR PersonGen BioTherapeutics (Suzhou) Co., Ltd. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04939090What this trial is testingOlanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsWho this might be right forAdvanced Malignant Solid NeoplasmAnorexiaHematopoietic and Lymphoid Cell Neoplasm Alliance for Clinical Trials in Oncology 227
Early research (Phase 1)Temporarily pausedNCT02333162What this trial is testingIntensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantWho this might be right forPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+1 more University of Chicago 30
Early research (Phase 1)Study completedNCT01324323What this trial is testingInfluence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerWho this might be right forHematologic MalignancyMalignant Lymphoma Celgene 14
Testing effectiveness (Phase 2)Looking for participantsNCT04984551What this trial is testingImpact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and EthiopiaWho this might be right forAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm M.D. Anderson Cancer Center 312
Early research (Phase 1)Ended earlyNCT05609942What this trial is testingStudy of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic MalignanciesWho this might be right forAdvanced Systemic Mastocytosis Blueprint Medicines Corporation 9